Functional Brands Inc. Receives Nasdaq Staff Delisting Determination
Lake Oswego, Oregon--(Newsfile Corp. - June 15, 2026) - Functional Brands Inc. (NASDAQ: MEHA) (the "Company"), a leading innovator in wellness and performance products, announced today that on June 9, 2026, it received a written notification (the "Staff Determination") from the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") indicating that Nasdaq has determined to delist the Company's common stock from The Nasdaq Capital Market. As previously disclosed, on D
Produits ménagers / de consommation / cosmétiques, Santé
2026-06-15 8:00 AM EDT | Functional Brands Inc.
Extendicare Announces June 2026 Dividend of C$0.0441 per Share
Markham, Ontario--(Newsfile Corp. - June 15, 2026) - Extendicare Inc. (TSX: EXE) ("Extendicare" or the "Company") announced that it has declared a cash dividend of C$0.0441 per common share of the Company for the month of June 2026, which is payable on July 15, 2026 to shareholders of record at the close of business on June 30, 2026. This dividend is designated as an "eligible dividend" within the meaning of the Income Tax Act (Canada). About Extendicare Extendicare i
Soins de santé et hôpitaux, Pharmaceutique, Santé
2026-06-15 8:00 AM EDT | Extendicare Inc.
CBIH Announces Patent-Related Scientific Framework for PTSD-Focused Cannabinoid and Psilocybin Research
Houston, Texas--(Newsfile Corp. - June 15, 2026) - Cannabis Bioscience International Holdings, Inc. (OTCID: CBIH), a public company trading under the ticker symbol CBIH, today announced a new chapter in its PTSD-focused research journey, marked by the completion of its patent-related work and the continued exploration of the scientific relationship between cannabinoids and psilocybin in relation to trauma, memory, emotional regulation, and recovery. PTSD affects veterans, first responde
Biotechnologies, Pharmaceutique, Cannabis, Santé
2026-06-15 7:00 AM EDT | Cannabis Bioscience International Holdings
Elite Pharmaceuticals Reports Positive Results from a Pivotal Bioequivalence Study
Northvale, New Jersey--(Newsfile Corp. - June 15, 2026) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty pharmaceutical company engaged in the development, manufacture, and distribution of niche generic products, today reported positive results from a pivotal bioequivalence study for an undisclosed anticonvulsant generic drug product. IQVIA reported branded and generic product sales for the twelve months ending April 2026 of $840 million.
Soins de santé et hôpitaux, Pharmaceutique, Santé
2026-06-15 7:00 AM EDT | Elite Pharmaceuticals, Inc.
Cosmo Welcomes the Launches of Winlevi(R) in Austria and Germany
Ireland and Heppenheim, Germany--(Newsfile Corp. - June 15, 2026) - Cosmo N.V. (SIX: COPN) (FSE: C43) (“Cosmo”) is pleased to announce the launch of its innovative acne cream Winlevi® (clascoterone 1% cream) in Austria and Germany by its commercial partner InfectoPharm Arzneimittel und Consilium GmbH (“InfectoPharm”). Winlevi® is available in both countries since June 1. Cosmo is the exclusive manufacturer of the product.
Soins de santé et hôpitaux, Santé
2026-06-15 1:01 AM EDT | Cosmo Pharmaceuticals N.V.
PreveCeutical Closes Second Tranche of Non-Brokered Private Placement
Vancouver, British Columbia--(Newsfile Corp. - June 12, 2026) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H0) (the "Company" or "PreveCeutical"), is pleased to announce that, further to its news releases dated May 12, 2026 and April 22, 2026, it has closed a second tranche (the "Second Tranche") of its previously announced non-brokered private placement (the "Offering"), which Second Tranche consisted of the issuance of 9,800,000 units
Biotechnologies, Pharmaceutique, Santé
2026-06-12 5:39 PM EDT | PreveCeutical Medical Inc.
Senior Care Authority Releases Father's Day Guide with 10 Warning Signs that Aging Parents Need Support
Incline Village, Nevada--(Newsfile Corp. - June 12, 2026) - Senior Care Authority shares insights on Father’s Day visits, highlighting how the occasion can help families notice when aging parents may be struggling in ways not visible from a distance. "Holiday visits are often when families first notice something has changed," said Frank Samson, founder and CEO of Senior Care Authority. "It's not always dramatic. Sometimes it's a messy kitchen or a conversation that feels sli
Soins de santé et hôpitaux, Santé
2026-06-12 9:00 AM EDT | Senior Care Authority
Akanda Corp. Regains Compliance with Nasdaq Periodic Filing Requirement
Toronto, Ontario--(Newsfile Corp. - June 12, 2026) - Akanda Corp. (NASDAQ: AKAN) (the "Company" or "Akanda"), today announced that on June 10, 2026, it received written notice from the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") confirming that the Company has regained compliance with Nasdaq Listing Rule 5250(c)(1), which requires listed companies to timely file all required periodic financial reports with the U.S. Securities and Exchange Commission (the "SEC")
Cannabis, Santé, Cultivateurs de cannabis, Producteurs de cannabis
2026-06-12 8:00 AM EDT | Akanda Corp
Neural Therapeutics Announces AGSM Results, CFO Appointment and Welcomes Positive Developments in the German Cannabis Market
Toronto, Ontario--(Newsfile Corp. - June 12, 2026) - Neural Therapeutics Inc. (CSE: NURL) (FSE: HANF) ("Neural" or the "Company") is pleased to announce the results of its annual general and special meeting of shareholders held on May 25, 2026 (the "Meeting"), including shareholder approval of the acquisition by Neural of the remaining 69.25% equity interest in CWE European Holdings Inc. ("CWE") not already owned by the Company, through a series of ancillary transa
Biotechnologies, Pharmaceutique, Santé, Psychédéliques
2026-06-12 7:30 AM EDT | Neural Therapeutics Inc.
Britannia Life Sciences Announces $5.3 Million Acquisition of Commercial Equipment Loan Portfolio
Toronto, Ontario--(Newsfile Corp. - June 12, 2026) - Britannia Life Sciences Inc. (CSE: BLAB) (the "Company" or "Britannia") is pleased to announce that it has completed a strategic investment of approximately $5.3 million in a portfolio of performing commercial equipment loans (the "Investment") on highly opportunistic terms. The Investment represents the continued execution of the Company's asset-backed lending strategy and meaningfully expands the Company's base of recurring, high-return c
Biotechnologies, Produits ménagers / de consommation / cosmétiques, Santé, Fournisseurs de services auxiliaires liés au cannabis
2026-06-12 7:30 AM EDT | Britannia Life Sciences Inc
WELL Health Provides a Corporate Update on Circle Medical
WELL Health is providing a corporate update on its majority-owned subsidiary Circle Medical, a leading telehealth platform delivering accessible, insurance-based primary care across the United States. Circle Medical continues to expand access to care, having more than tripled the number of commercially insured patients eligible to receive care on its platform over the last year, supported by strong double-digit growth in new patient bookings and activations in May 2026 as compare
Technologies, Logiciels, Soins de santé et hôpitaux, Santé
2026-06-12 7:00 AM EDT | WELL Health Technologies Corp.
Cheelcare Announces a Non-Brokered Private Placement to Raise up to $1.5 Million
Markham, Ontario--(Newsfile Corp. - June 11, 2026) - Cheelcare Inc. (TSXV: CHER) (OTC: CHCRF) ("Cheelcare" or the "Company"), a Canadian innovator in advanced mobility solutions, announces a non-brokered private placement for the issuance of up to 1,000,000 units of the Company (the "Units") at a price of $1.50 per Unit for aggregate gross proceeds of up to $1,500,000 (the "Offering"). Each Unit consists of one common share in the capital of the Company (a "Share") and one-half of one
2026-06-11 4:30 PM EDT | Cheelcare Inc.
Edison Issues Report on SCHMID (SHMD)
London, United Kingdom--(Newsfile Corp. - June 11, 2026) - Edison issues report on SCHMID (NASDAQ: SHMD). SCHMID is a designer and manufacturer of equipment used in the electronics industry for printed circuit board (PCB) and advanced packaging manufacturing. Focused on the higher end of the sector where advances in packaging are driving demand for new processes and materials, SCHMID has developed cutting-edge tools and patented processes. After a couple of years of weaker demand, manag
Services bancaires / financiers, Matériel informatique, Logiciels, Santé
2026-06-11 11:43 AM EDT | Edison Group
Tersis Technologies and Pingkas Capital Sign MOU to Deploy Syngenic V3 Waste-to-Energy Platform in the Philippines
Brooksville, Florida--(Newsfile Corp. - June 11, 2026) - Tersis Technologies, Inc. (OTCID: TERS) ("Tersis"), a developer of advanced waste-to-energy and circular-economy technologies, today announced that it has signed a Memorandum of Understanding (MOU) with JL Equities Cap, LLC, doing business as Pingkas Capital ("Pingkas"), to jointly develop, finance, deploy, and operate waste-to-energy projects in the Republic of the Philippines using the Tersis Syngenic V3 technology platform.
Agriculture, Énergie, Énergies de substitution, Santé
2026-06-11 10:13 AM EDT | Tersis Technologies Inc.
CBD of Denver Announces Strategic Exploration of Merger Candidates
Wallisellen, Switzerland--(Newsfile Corp. - June 11, 2026) - CBD of Denver, Inc. (OTC Pink: CBDD) today announced that its Board of Directors has authorized a strategic review of three merger candidates operating within the artificial intelligence (AI) industry. Management is identifying and evaluating their potential and how potentially CBDD will have benefit of it. The Company is specifically focused on businesses that are actively developing and deploying AI-powered tools designed t
Cannabis, Santé, Extracteurs de cannabis, Producteurs de cannabis
2026-06-11 9:00 AM EDT | CBD of Denver Inc.
Cosmo Welcomes the Launch of Winlevi(R) in Key European Markets by Its Partner Glenmark
Dublin, Ireland--(Newsfile Corp. - June 11, 2026) - Cosmo N.V. (SIX: COPN) (XETRA: C43) (“Cosmo”) is pleased to make known that its commercial partner Glenmark Specialty S.A (GSSA), a wholly-owned subsidiary of Glenmark Pharmaceuticals Ltd., today announced the launch of Winlevi® (clascoterone 10 mg/g cream) across key markets in Europe. This follows the grant of marketing authorization of the product for the tr
Soins de santé et hôpitaux, Santé
2026-06-11 1:19 AM EDT | Cosmo Pharmaceuticals N.V.
Psyched Wellness Provides Corporate Update
Toronto, Ontario--(Newsfile Corp. - June 10, 2026) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company" or "Psyched Wellness"), a life sciences company focused on the production and distribution of health and wellness products derived from the Amanita Muscaria mushroom, announces that Jeff Stevens has stepped down from his position as Chief Executive Officer and resigned as a director of the Company, each effective May 31, 2026. Mr. Stevens has also resign
Cannabis, Santé, Psychédéliques, Producteurs de cannabis
2026-06-10 5:15 PM EDT | Psyched Wellness Ltd.
Adia Nutrition Inc. Delivers Exciting Update: Name Change to Adia Med Inc. Now Official in Nevada
Winter Park, Florida--(Newsfile Corp. - June 10, 2026) - Adia Nutrition Inc. (OTCQB: ADIA) is pleased to confirm that the State of Nevada has officially approved the company's name change to Adia Med Inc.
Soins de santé et hôpitaux, Santé
2026-06-10 9:15 AM EDT | Adia Nutrition Inc.
Restart Life Subsidiary Holy Crap Foods Marks New International Expansion Milestone with Bahamas On-Demand App Launch
Vancouver, British Columbia--(Newsfile Corp. - June 10, 2026) - Restart Life Sciences Corp. (CSE: HEAL) (FSE: HN30) (OTC Pink: NMLSF) ("Restart Life" or the "Company") is pleased to announce that its wholly owned subsidiary, Holy Crap Foods Inc., has officially launched a targeted market test and comprehensive product trial across the Commonwealth of The Bahamas. The pilot program is being executed in direct partnership with a premier mobile-first delivery application, digital logistics, and
Technologies, Biotechnologies, Santé
2026-06-10 8:00 AM EDT | Restart Life Sciences Corp.
Custom Health Announces Closing of the Acquisition of InnovativeRx Operating Subsidiaries to Expand Integrated Medication Management Infrastructure Across North America
Strategic Acquisition: Custom Health announces the closing of the acquisition of substantially all of the operating assets of InnovativeRx US Holdings, Inc. ("InnovativeRx") to expand its integrated healthcare infrastructure across North America. InnovativeRx is an existing operational partner already utilizing Custom Health's proprietary AdhereNet® platform, enabling streamlined integration and workflow continuity. F
Technologies, Pharmaceutique, Santé
2026-06-10 7:00 AM EDT | Custom Health Holdings Inc.